Risdiplam Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 0.75 mg/mL
Reference Brands: Evrysdi (USA/EU)
Category: Neurology
Risdiplam is an oral survival motor neuron 2 (SMN2) splicing modifier used to treat spinal muscular atrophy (SMA) in adults and children aged 2 months and older. It works by increasing the production of functional SMN protein, essential for maintaining motor neuron function. Risdiplam helps improve muscle strength and slow disease progression in SMA patients. Risdiplam is available in Oral Solution and strengths such as 0.75 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Risdiplam is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Risdiplam can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Risdiplam is used for the treatment of spinal muscular atrophy (SMA) in patients two months of age and older.
Risdiplam is made from a small-molecule splicing modifier that increases the production of functional survival motor neuron (SMN) protein in the body.
The trade name of Risdiplam is Evrysdi.
Risdiplam is made by Genentech, a member of the Roche Group, in collaboration with PTC Therapeutics and the SMA Foundation.
The generic name of the product is Risdiplam.
The brand name of Risdiplam is Evrysdi.
Risdiplam is manufactured by Genentech, Inc. in the United States.
Related Products
Memantine
Strength:
5 mg, 10 mg, 10 mg/5 ml
Form: Tablets / Oral solution
Reference Brands: Namenda (USA), Ebixa (EU/UK)
View Details
Sodium Oxybate
Strength:
500 mg/ml
Form: Oral Solution
Reference Brands: Xyrem (USA/EU), Lumryz (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
